🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial tests the safety, side effects and best dose of azacitid...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2027-01-03
Trial ID
NCT07691450
To define Phase 1/2 Maximum Tolerated Dose Study of Belinostat (PXD-101) in...
Status
Completed
Location
Clearview Cancer Institute (CCI)
Start Date
2010-12
Trial ID
NCT01310244
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02701673
This is a Phase I dose escalation study of PXD101 administered orally. Oral...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2006-06
Trial ID
NCT00413075
Treatments Being Tested
This phase I trial studies the side effects and best dose of belinostat whe...
Status
Active Not Recruiting
Location
Huntsman Cancer Institute/University of Utah
Start Date
2022-01-14
Trial ID
NCT05154994
Treatments Being Tested
This is an open-label, extension protocol designed to allow patients to con...
Status
Completed
Location
John Wayne Cancer Institute @ Providence Saint John's Health Center
Start Date
2019-08-05
Trial ID
NCT04184869
Treatments Being Tested
The purpose of this study is to find out whether the combination treatment ...
Status
Recruiting
Location
VA Long Beach Health Care System
Start Date
2021-02-19
Trial ID
NCT04747236
Treatments Being Tested
This study looks at what effects (good and bad) a drug called PXD-101 (beli...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2012-08-31
Trial ID
NCT01686165
Treatments Being Tested
An open-label, non-randomized, multi-centre, Phase I/II trial to assess the...
Status
Completed
Location
CHU Lapeyronie
Start Date
2007-08
Trial ID
NCT00878722
Treatments Being Tested
RATIONALE: Belinostat and bortezomib may stop the growth of cancer cells by...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2010-05
Trial ID
NCT01075425